WARREN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement ...
-- Royalties Based on Annual Net Sales of MOLBREEVI in the U.S.-- -- Funds Will Strengthen the Company’s Balance Sheet for Potential U.S. Commercialization of MOLBREEVI in Autoimmune PAP -- The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback